Figure 2.

Administration of Cet-IRDye800 associated with the liposomal molecules leads to the nanotheranotics drug delivery system. It helps the drug molecule to target the tumor mass. There is very low concentration of drug in normal cells which helps to reduce the adverse events of drugs. Cet-IRDye800 has dual action of therapeutic as well as diagnostic(targeting). This conjugated molecule increases the rate of delivery along with the extent of delivery. It increases the diagnostic accuracy of the molecule. This approach helps to remove the tumor through the surgical method after detecting its accurate position. Adopted by CC by 4 from ²⁹.